According to the Zhitong Finance App, Mace Health (02415) announced the 2026 interim results. The group's revenue for the period was 117 million yuan (RMB, same below), a year-on-year decrease of 6.2%; net profit of 10.638 million yuan, a year-on-year decrease of 19.7%; and a basic profit of 1.94 points per share.

According to the announcement, the decline in earnings is mainly driven by a decrease in the demand for clinical research in some simple languages due to the spread of AI technology.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.